Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Sexually transmitted diseases are infections that are passed from one person to another through sexual contact.
The report details the trend, potential and market size of Sexually Transmitted Disease Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Sexually Transmitted Disease Therapeuticsmarket, defines the market attractiveness level of Sexually Transmitted Disease Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Sexually Transmitted Disease Therapeutics industry, describes the types of Sexually Transmitted Disease Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Sexually Transmitted Disease Therapeutics market and the development prospects and opportunities of Sexually Transmitted Disease Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Sexually Transmitted Disease Therapeutics market in Chapter 13.
By Player:
Hologic Inc
Alere Inc
Danaher Corporation
Orasure
Abbott Laboratories
Cepheid Inc
Roche Holdings AG
Becton Dickinson and Company
bioMerieux
Affymetrix
DiaSorin
By Type:
Gonorrhea
Syphilis
Chlamydia
Trichomoniasis
By End-User:
Hospitals
Diagnostic Laboratories
Research and Academic Laboratories
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Sexually Transmitted Disease Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Sexually Transmitted Disease Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Sexually Transmitted Disease Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Sexually Transmitted Disease Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Sexually Transmitted Disease Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Sexually Transmitted Disease Therapeutics Consumption (2017-2022)
-
7.2 United States Sexually Transmitted Disease Therapeutics Consumption (2017-2022)
-
7.3 Europe Sexually Transmitted Disease Therapeutics Consumption (2017-2022)
-
7.4 China Sexually Transmitted Disease Therapeutics Consumption (2017-2022)
-
7.5 Japan Sexually Transmitted Disease Therapeutics Consumption (2017-2022)
-
7.6 India Sexually Transmitted Disease Therapeutics Consumption (2017-2022)
-
7.7 South Korea Sexually Transmitted Disease Therapeutics Consumption (2017-2022)
8 Region and Country-wise Sexually Transmitted Disease Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Sexually Transmitted Disease Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Sexually Transmitted Disease Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Sexually Transmitted Disease Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Sexually Transmitted Disease Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Sexually Transmitted Disease Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Sexually Transmitted Disease Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Sexually Transmitted Disease Therapeutics Consumption Forecast (2022-2028)
9 Global Sexually Transmitted Disease Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Sexually Transmitted Disease Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Gonorrhea Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Syphilis Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Chlamydia Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Trichomoniasis Consumption and Growth Rate (2017-2022)
-
9.2 Global Sexually Transmitted Disease Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Diagnostic Laboratories Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Research and Academic Laboratories Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Sexually Transmitted Disease Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Sexually Transmitted Disease Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Gonorrhea Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Syphilis Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Chlamydia Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Trichomoniasis Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Sexually Transmitted Disease Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Diagnostic Laboratories Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Research and Academic Laboratories Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Sexually Transmitted Disease Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Sexually Transmitted Disease Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Sexually Transmitted Disease Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Sexually Transmitted Disease Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Sexually Transmitted Disease Therapeutics Market Competitive Analysis
-
14.1 Hologic Inc
-
14.1.1 Hologic Inc Company Details
-
14.1.2 Hologic Inc Sexually Transmitted Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Hologic Inc Sexually Transmitted Disease Therapeutics Product and Service
-
14.2 Alere Inc
-
14.2.1 Alere Inc Company Details
-
14.2.2 Alere Inc Sexually Transmitted Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Alere Inc Sexually Transmitted Disease Therapeutics Product and Service
-
14.3 Danaher Corporation
-
14.3.1 Danaher Corporation Company Details
-
14.3.2 Danaher Corporation Sexually Transmitted Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Danaher Corporation Sexually Transmitted Disease Therapeutics Product and Service
-
14.4 Orasure
-
14.4.1 Orasure Company Details
-
14.4.2 Orasure Sexually Transmitted Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Orasure Sexually Transmitted Disease Therapeutics Product and Service
-
14.5 Abbott Laboratories
-
14.5.1 Abbott Laboratories Company Details
-
14.5.2 Abbott Laboratories Sexually Transmitted Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Abbott Laboratories Sexually Transmitted Disease Therapeutics Product and Service
-
14.6 Cepheid Inc
-
14.6.1 Cepheid Inc Company Details
-
14.6.2 Cepheid Inc Sexually Transmitted Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Cepheid Inc Sexually Transmitted Disease Therapeutics Product and Service
-
14.7 Roche Holdings AG
-
14.7.1 Roche Holdings AG Company Details
-
14.7.2 Roche Holdings AG Sexually Transmitted Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Roche Holdings AG Sexually Transmitted Disease Therapeutics Product and Service
-
14.8 Becton Dickinson and Company
-
14.8.1 Becton Dickinson and Company Company Details
-
14.8.2 Becton Dickinson and Company Sexually Transmitted Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Becton Dickinson and Company Sexually Transmitted Disease Therapeutics Product and Service
-
14.9 bioMerieux
-
14.9.1 bioMerieux Company Details
-
14.9.2 bioMerieux Sexually Transmitted Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 bioMerieux Sexually Transmitted Disease Therapeutics Product and Service
-
14.10 Affymetrix
-
14.10.1 Affymetrix Company Details
-
14.10.2 Affymetrix Sexually Transmitted Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Affymetrix Sexually Transmitted Disease Therapeutics Product and Service
-
14.11 DiaSorin
-
14.11.1 DiaSorin Company Details
-
14.11.2 DiaSorin Sexually Transmitted Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 DiaSorin Sexually Transmitted Disease Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Sexually Transmitted Disease Therapeutics
-
Figure Sexually Transmitted Disease Therapeutics Picture
-
Table Global Sexually Transmitted Disease Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Sexually Transmitted Disease Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Sexually Transmitted Disease Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Sexually Transmitted Disease Therapeutics Consumption by Country (2017-2022)
-
Figure United States Sexually Transmitted Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Sexually Transmitted Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Sexually Transmitted Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Sexually Transmitted Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Sexually Transmitted Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Sexually Transmitted Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Sexually Transmitted Disease Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Sexually Transmitted Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Sexually Transmitted Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Sexually Transmitted Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Sexually Transmitted Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Sexually Transmitted Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Sexually Transmitted Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gonorrhea Consumption and Growth Rate (2017-2022)
-
Figure Global Syphilis Consumption and Growth Rate (2017-2022)
-
Figure Global Chlamydia Consumption and Growth Rate (2017-2022)
-
Figure Global Trichomoniasis Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostic Laboratories Consumption and Growth Rate (2017-2022)
-
Figure Global Research and Academic Laboratories Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Gonorrhea Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Syphilis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chlamydia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Trichomoniasis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostic Laboratories Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research and Academic Laboratories Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Sexually Transmitted Disease Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Sexually Transmitted Disease Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Hologic Inc (Foundation Year, Company Profile and etc.)
-
Table Hologic Inc Sexually Transmitted Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hologic Inc Sexually Transmitted Disease Therapeutics Product and Service
-
Table Alere Inc (Foundation Year, Company Profile and etc.)
-
Table Alere Inc Sexually Transmitted Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alere Inc Sexually Transmitted Disease Therapeutics Product and Service
-
Table Danaher Corporation (Foundation Year, Company Profile and etc.)
-
Table Danaher Corporation Sexually Transmitted Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Danaher Corporation Sexually Transmitted Disease Therapeutics Product and Service
-
Table Orasure (Foundation Year, Company Profile and etc.)
-
Table Orasure Sexually Transmitted Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Orasure Sexually Transmitted Disease Therapeutics Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Sexually Transmitted Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Sexually Transmitted Disease Therapeutics Product and Service
-
Table Cepheid Inc (Foundation Year, Company Profile and etc.)
-
Table Cepheid Inc Sexually Transmitted Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cepheid Inc Sexually Transmitted Disease Therapeutics Product and Service
-
Table Roche Holdings AG (Foundation Year, Company Profile and etc.)
-
Table Roche Holdings AG Sexually Transmitted Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Holdings AG Sexually Transmitted Disease Therapeutics Product and Service
-
Table Becton Dickinson and Company (Foundation Year, Company Profile and etc.)
-
Table Becton Dickinson and Company Sexually Transmitted Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Becton Dickinson and Company Sexually Transmitted Disease Therapeutics Product and Service
-
Table bioMerieux (Foundation Year, Company Profile and etc.)
-
Table bioMerieux Sexually Transmitted Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table bioMerieux Sexually Transmitted Disease Therapeutics Product and Service
-
Table Affymetrix (Foundation Year, Company Profile and etc.)
-
Table Affymetrix Sexually Transmitted Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Affymetrix Sexually Transmitted Disease Therapeutics Product and Service
-
Table DiaSorin (Foundation Year, Company Profile and etc.)
-
Table DiaSorin Sexually Transmitted Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table DiaSorin Sexually Transmitted Disease Therapeutics Product and Service
-
